RALEIGH, N.C., Nov. 2 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, announces the opening of a new office facility in Seoul, South Korea. To accommodate rapid growth and further broaden PRA’s ability to deliver clinical service excellence, the company has moved its Seoul, South Korea office to a larger, more centrally located facility.
South Korea is widely regarded as the third most important pharmaceutical market in Asia and as one of the most important Asian countries for clinical studies to support new drug registrations. “The increasing demand for study work in South Korea drove the need for increased capacity,” said Dr. Ludger Langer, PRA’s Vice President - Clinical Operations, Europe, Asia-Pacific, Africa. “We are now better positioned to meet the continued needs of our customers in this region.”
About PRA International
PRA’s therapeutic expertise, global reach and project experience, combined with extensive local knowledge and our differentiating PERSONAL ELEMENT enable our project teams to deliver consistent and on time performance for our clients. This unique PRA philosophy - THE PERSONAL ELEMENT - recognizes that true client service comes only from trained, empowered and dedicated employees who are encouraged to use innovation and their personal commitment to accelerate the development life cycle.
PRA International
